CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia
Summary
GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Russian pharmaceutical market was worth $29.6B in 2012, but declined to $22.7B by 2016 due to the devaluation of the Russian ruble during the Russian Financial Crisis (2014-2017). By 2018, the economy had recovered and the pharmaceutical market had grown to $26.8B. It is forecast to reach $38.5B by 2025 at a Compound Annual Growth Rate (CAGR) of 5.3%. The Russian pharmaceutical market faces stiff competition from generic drugs. In 2018, generic drugs accounted for 61.8% of sales of the retail commercial market, while original drugs accounted for 38.2%. In 2015, the medical devices market in Russia was worth $7.07B, which increased to $7.92B in 2019. It is expected to grow at a CAGR of 4.1% from 2019 to reach $10.07B in 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Novartis, Pfizer, GlaxoSmithKline, and Pharmstandard.
- Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Roche, Essilor, and Zimmer Biomet
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Russian healthcare market
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Russia’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Russia’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
- Table of Contents
- 1.1 List of Figures
- 1.2 List of Tables
- 2 Executive Summary
- 2.1 Executive Summary
- 2.2 Key Highlights
- 2.3 Key Events: Russian Pharmaceutical News, 2014-
- 2.4 Key Events: Russian Pharmaceutical Market
- 2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-
- 2.6 Key Events: Mergers and Acquisitions
- 2.7 Country Profile, Russia,
- 3 Overview of Pharmaceutical Market
- 3.1 Pharmaceutical Market - Overview
- 3.2 Pharmaceutical Market - Pharma
- 3.3 Pharmaceutical Market - Exports
- 3.4 Pharmaceutical Market - Imports
- 3.5 Pharmaceutical Supply Channels, Russia
- 3.5 Pharmaceutical Market - Market Segments
- 3.6 Major Therapeutic Areas, Russia
- 3.7 COVID-19 Epidemiology, Russia
- 3.8 COVID-19 Impact and Developments in Healthcare Market, Russia
- 3.9 Pharmaceutical Market - Major Players
- 4 Overview of Medical Devices Market
- 4.1 Medical Device Market - Overview
- 4.2 Medical Device Market - Major Segments
- 4.3 Medical Device Market - Major Players
- 5 Pharmaceutical and Medical Device Market - Drivers and Barriers
- 5.1 Drivers
- 5.2 Barriers
- 6 Deal Analysis
- 6.1 Deal Analysis: Pharmaceutical Market, Russia 2019-
- 6.2 Deal Analysis: Medical Devices, Russia 2019-
- 7 HealthTech Landscape
- 7.1 HealthTech Landscape
- 7.2 Digital Health Companies, Russia
- 7.3 Key HealthTech Deals, Russia
- 7.4 Telemedicine Regulations, Russia
- 7.5 HealthTech Landscape- Russia- Benefits and Risks
- 8 Market Access
- 8.1 Overview of Healthcare System, Russia
- 8.2 Reimbursement Process, Russia
- 8.3 Overview of Health Insurance, Russia
- 8.4 Healthcare Spending and Health Price Index, Russia
- 8.5 Pricing Policies, Russia
- 8.6 Regulatory Landscape, Russia
- 8.6.1 Market Authorization for Pharmaceutical Drugs, Russia
- 8.6.2 Regulatory Reforms, Russia
- 8.6.3 Market Authorization for Medical Devices, Russia
- 8.6.4 Licensing Process for Pharmaceutical Exports and Imports
- 8.6.5 Intellectual Property Rights, Patent, Russia
- 8.6.5 Clinical Trial Regulations, Russia
- 8.6.6 Pharmaceutical Clinical Trials Landscape, Russia
- 8.6.7 Pharmaceutical Advertising Regulations, Russia
- 8.6.8 Labeling Regulations, Russia
- 9 Country Healthcare Landscape
- 9.1 Healthcare Initiatives
- 9.2 Healthcare Facilities, Russia
- 9.3 Healthcare Parameters, Russia
- 9.4 Life Expectancy and Immunization Rate, Russia
- 9.5 Environmental Health, Russia
- 9.6 Healthcare Personnel, Russia
- 9.7 Disease Burden, Russia
- 9.8 Healthcare Expenditure
- 10 Trade Associations, Russia
- 11 Trade Fairs, Russia
- 12 Opportunities and Challenges
- 13 Appendix
- 13.1 Research Methodology
- 13.1.1 Coverage
- 13.1.2 Secondary Research
- 13.1.3 Forecasts
- 13.1.4 Expert Panel
- 13.2 Bibliography
- 13.3 Contact Us
- 13.4 Disclaimer
- List of Tables
- Table 1: Major Pharmaceutical Distributors, Russia, 2018
- Table 2: Sales Structure of RTU drugs by ATC groups, Russia, 2018
- Table 3: COVID-19 Indicators (Number of cases), Global and Russia, 2020
- Table 4: COVID-19 Clinical Trials, Russia, 2020
- Table 5: COVID-19 Test Kits, Russia, 2020
- Table 6: Orthopedic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 7: Ophthalmic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
- Table 8: Diagnostic Imaging Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
- Table 9: Cardiovascular Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Table 10: In Vitro Diagnostics Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
- Table 11: Out-Patient Drug Reimbursement Eligibility, Russia, 2019
- Table 12: Medical Equipment Risk Classification, Russia, 2019
- Table 13: Patent Fees, Russia, 2019
- Table 14: Trade Fairs, 2020
- List of Figures
- Figure 1: Pharmaceutical Market, Russia, Revenue ($B), 2012-2018
- Figure 2: Medical Device Market, Russia, Revenue ($B), 2015-2020
- Figure 3: Country Profile, Russia, 2019
- Figure 4: Pharmaceutical Market, Russia, Revenue (RUB B and $B), 2012-2018
- Figure 5: Pharmaceutical Market, Russia, Revenue Forecast (RUB B and $B), 2019-2025
- Figure 6: Pharma 2020, Russia, 2020
- Figure 7: Pharmaceutical Exports ($M), Russia, 2010-2019
- Figure 8: Top Export Partners, Russia, 2019
- Figure 9: Pharmaceutical Imports ($B), Russia, 2010-2019
- Figure 10: Top Import Partners, Russia, 2019
- Figure 11: OTC Market, Russia, Major Category (%), 2019
- Figure 12: OTC Market, Russia, Revenue ($M), 2013-2020
- Figure 13: COVID-19 (Number of cases), Russia, 2020
- Figure 14: COVID-19 (Number of deaths), Russia, 2020
- Figure 15: Pharmaceutical Market, Major Players, 2018
- Figure 16: Medical Device Market, Russia, Revenue ($B), 2015-2020
- Figure 17: Medical Device Market, Russia, Revenue Forecast ($B), 2021-2025
- Figure 18: Medical Devices Market, Major Segments (%), Russia, 2019
- Figure 19: Orthopedic Devices Market, Russia, Revenue ($M), 2015-2022
- Figure 20: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2019
- Figure 21: Ophthalmic Devices Market, Russia, Revenue ($M), 2015-2022
- Figure 22: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015
- Figure 23: Diagnostic Imaging Market, Russia, Revenue ($M), 2015-2022
- Figure 24: Diagnostic Imaging Market, Russia, Market Share of Major Players (%), 2015
- Figure 25: Cardiovascular Devices Market, Russia, Revenue ($M), 2015-2022
- Figure 26: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2018
- Figure 27: In Vitro Diagnostics Market, Russia, Revenue ($M), 2015-2022
- Figure 28: In Vitro Diagnostics Market, Russia, Market Share of Major Players (%), 2015
- Figure 29: Diagnostic Market, Russia, Revenue ($M), 2015-2020
- Figure 30: Diagnostic Market, Russia, Revenue ($M), 2021-2025
- Figure 31: Medical Device Market, Russia, Revenue ($B) of Major Companies, 2017
- Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Russia, 2019-2020
- Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Russia, 2019-2020
- Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Russia, 2019-2020
- Figure 35: Top Therapy Areas by Deal Value, Pharmaceutical Market, Russia, 2019-2020
- Figure 36: Top Therapy Areas by Deal Number, Pharmaceutical Market, Russia, 2019-2020
- Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Russia, 2019-2020 (by value and by number)
- Figure 38: Deal Value and Deal Count, Medical Devices, Russia, 2019-2020
- Figure 39: Deal Value and Deal Count Quarterly, Medical Devices, Russia, 2019-2020
- Figure 40: Overview of Healthcare System, Russia, 2019
- Figure 41: Public Provision of Pharmaceuticals, Russia, 2019
- Figure 42: Government Health Insurance (% of population), Russia, 2010-2018
- Figure 43: Out-of-Pocket Expenditure ($ per capita), Russia, 2010-2017
- Figure 44: Health Price Index (% change), Russia, 2011-2019
- Figure 45: Drug price regulation, Russia, 2019
- Figure 46: Filing Procedure for Registration of Maximum Selling Price for EDL Drugs, Russia, 2019
- Figure 47: Roszdravnadzor, Organization Chart, 2020
- Figure 48: Rospotrebnadzor, Organization Chart, 2020
- Figure 49: Drug Approval Process, Russia, 2019
- Figure 50: Drug Approval Overall Process, Russia, 2019
- Figure 51: Rospatent Organization Structure, Russia, 2019
- Figure 52: Patent Application Process, Russia, 2019
- Figure 53: Pharmaceutical Clinical Trials Count By Trial Status, Russia, 2018-2019
- Figure 54: Pharmaceutical Clinical Trials Count By Phase, Russia, 2018-2019
- Figure 55: Pharmaceutical Clinical Trials Count By Therapy Area, Russia, 2018-2019
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook